The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 25, 2016
Filed:
Apr. 12, 2012
Applicants:
Alex Karlsson-parra, Uppsala, SE;
Anna-carin Wallgren, Uppsala, SE;
Bengt Andersson, Mölndal, SE;
Inventors:
Assignee:
IMMUNICUM AB, Gothenburg, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01); A61K 35/17 (2015.01); C12N 5/0784 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); A61K 35/17 (2013.01); A61K 39/0011 (2013.01); C12N 5/0639 (2013.01); A61K 2039/5156 (2013.01); C12N 2500/40 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2301 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2304 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/24 (2013.01); C12N 2501/25 (2013.01); C12N 2501/515 (2013.01); C12N 2502/11 (2013.01);
Abstract
The present invention relates to an in vitro method for priming genetically modified T cells suitable for administration to a patient having a tumor. The invention is also directed to the composition obtained by the method and uses thereof.